163 related articles for article (PubMed ID: 32830515)
41. Rad51 supports triple negative breast cancer metastasis.
Wiegmans AP; Al-Ejeh F; Chee N; Yap PY; Gorski JJ; Da Silva L; Bolderson E; Chenevix-Trench G; Anderson R; Simpson PT; Lakhani SR; Khanna KK
Oncotarget; 2014 May; 5(10):3261-72. PubMed ID: 24811120
[TBL] [Abstract][Full Text] [Related]
42. Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51.
Wang B; Hou D; Liu Q; Wu T; Guo H; Zhang X; Zou Y; Liu Z; Liu J; Wei J; Gong Y; Shao C
Cancer Biol Ther; 2015; 16(10):1548-56. PubMed ID: 26176175
[TBL] [Abstract][Full Text] [Related]
43. 135G>C and 172G>T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women.
Smolarz B; Samulak D; Michalska M; Góralczyk B; Szyłło K; Lewy J; Sporny S; Kokołaszwili G; Burzyński M; Romanowicz-Makowska H
Pol J Pathol; 2011 Sep; 62(3):157-62. PubMed ID: 22102073
[TBL] [Abstract][Full Text] [Related]
44. DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway.
Chiu WC; Fang PT; Lee YC; Wang YY; Su YH; Hu SC; Chen YK; Tsui YT; Kao YH; Huang MY; Yuan SF
Ann Surg Oncol; 2020 Jun; 27(6):2090-2101. PubMed ID: 31749080
[TBL] [Abstract][Full Text] [Related]
45. Regulation of Gli2 stability by deubiquitinase OTUB2.
Li XY; Mao XF; Tang XQ; Han QQ; Jiang LX; Qiu YM; Dai J; Wang YX
Biochem Biophys Res Commun; 2018 Oct; 505(1):113-118. PubMed ID: 30241937
[TBL] [Abstract][Full Text] [Related]
46. hCAS/CSE1L regulates RAD51 distribution and focus formation for homologous recombinational repair.
Okimoto S; Sun J; Fukuto A; Horikoshi Y; Matsuda S; Matsuda T; Ikura M; Ikura T; Machida S; Kurumizaka H; Miyamoto Y; Oka M; Yoneda Y; Kiuchi Y; Tashiro S
Genes Cells; 2015 Sep; 20(9):681-94. PubMed ID: 26123175
[TBL] [Abstract][Full Text] [Related]
47. Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill.
Xie X; He G; Siddik ZH
Mol Pharmacol; 2020 Apr; 97(4):237-249. PubMed ID: 32063580
[TBL] [Abstract][Full Text] [Related]
48. Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.
Sanchez-Bailon MP; Choi SY; Dufficy ER; Sharma K; McNee GS; Gunnell E; Chiang K; Sahay D; Maslen S; Stewart GS; Skehel JM; Dreveny I; Davies CC
Nat Commun; 2021 Nov; 12(1):6313. PubMed ID: 34728620
[TBL] [Abstract][Full Text] [Related]
49. A mRad51-GFP antimorphic allele affects homologous recombination and DNA damage sensitivity.
Uringa EJ; Baldeyron C; Odijk H; Wassenaar E; van Cappellen WA; Maas A; Hoeijmakers JH; Baarends WM; Kanaar R; Essers J
DNA Repair (Amst); 2015 Jan; 25():27-40. PubMed ID: 25463395
[TBL] [Abstract][Full Text] [Related]
50. Targeting RAD51 enhances chemosensitivity of adult T‑cell leukemia‑lymphoma cells by reducing DNA double‑strand break repair.
Yang M; Tian X; Fan Z; Yu W; Li Z; Zhou J; Zhang W; Liang A
Oncol Rep; 2019 Dec; 42(6):2426-2434. PubMed ID: 31638261
[TBL] [Abstract][Full Text] [Related]
51. Glu-108 in Saccharomyces cerevisiae Rad51 Is Critical for DNA Damage-Induced Nuclear Function.
Suhane T; Bindumadhavan V; Fangaria N; Nair AS; Tabassum W; Muley P; Bhattacharyya MK; Bhattacharyya S
mSphere; 2019 Mar; 4(2):. PubMed ID: 30894431
[TBL] [Abstract][Full Text] [Related]
52. Promotion of homology-directed DNA repair by polyamines.
Lee CY; Su GC; Huang WY; Ko MY; Yeh HY; Chang GD; Lin SJ; Chi P
Nat Commun; 2019 Jan; 10(1):65. PubMed ID: 30622262
[TBL] [Abstract][Full Text] [Related]
53. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
[TBL] [Abstract][Full Text] [Related]
54. Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae.
Kalimutho M; Bain AL; Mukherjee B; Nag P; Nanayakkara DM; Harten SK; Harris JL; Subramanian GN; Sinha D; Shirasawa S; Srihari S; Burma S; Khanna KK
Mol Oncol; 2017 May; 11(5):470-490. PubMed ID: 28173629
[TBL] [Abstract][Full Text] [Related]
55. Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance.
Krumm A; Barckhausen C; Kücük P; Tomaszowski KH; Loquai C; Fahrer J; Krämer OH; Kaina B; Roos WP
Cancer Res; 2016 May; 76(10):3067-77. PubMed ID: 26980768
[TBL] [Abstract][Full Text] [Related]
56. Rad18 and Rnf8 facilitate homologous recombination by two distinct mechanisms, promoting Rad51 focus formation and suppressing the toxic effect of nonhomologous end joining.
Kobayashi S; Kasaishi Y; Nakada S; Takagi T; Era S; Motegi A; Chiu RK; Takeda S; Hirota K
Oncogene; 2015 Aug; 34(33):4403-11. PubMed ID: 25417706
[TBL] [Abstract][Full Text] [Related]
57. [RAD51 regulates REV1 recruitment to DNA double-strand
break sites].
Huang M; Yang YR; Sun XY; Zhang T; Guo CX
Yi Chuan; 2018 Nov; 40(11):1007-1014. PubMed ID: 30465533
[TBL] [Abstract][Full Text] [Related]
58. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin.
Koehn H; Magan N; Isaacs RJ; Stowell KM
Anticancer Drugs; 2007 Apr; 18(4):419-25. PubMed ID: 17351394
[TBL] [Abstract][Full Text] [Related]
59. Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases.
Sivakumar D; Kumar V; Naumann M; Stein M
J Biol Chem; 2020 May; 295(20):6972-6982. PubMed ID: 32265297
[TBL] [Abstract][Full Text] [Related]
60. The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors.
Mason JM; Logan HL; Budke B; Wu M; Pawlowski M; Weichselbaum RR; Kozikowski AP; Bishop DK; Connell PP
Cancer Res; 2014 Jul; 74(13):3546-55. PubMed ID: 24753542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
